Correlation Between Monopar Therapeutics and Metacrine
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Metacrine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Metacrine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Metacrine, you can compare the effects of market volatilities on Monopar Therapeutics and Metacrine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Metacrine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Metacrine.
Diversification Opportunities for Monopar Therapeutics and Metacrine
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Monopar and Metacrine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Metacrine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metacrine and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Metacrine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metacrine has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Metacrine go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Metacrine
If you would invest 645.00 in Monopar Therapeutics on November 27, 2024 and sell it today you would earn a total of 2,954 from holding Monopar Therapeutics or generate 457.98% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Monopar Therapeutics vs. Metacrine
Performance |
Timeline |
Monopar Therapeutics |
Metacrine |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Monopar Therapeutics and Metacrine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Monopar Therapeutics and Metacrine
The main advantage of trading using opposite Monopar Therapeutics and Metacrine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Metacrine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metacrine will offset losses from the drop in Metacrine's long position.Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |